Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Shares Outstanding (Weighted Average) (2024 - 2025)

Historic Shares Outstanding (Weighted Average) for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $62.6 million.

  • Pyxis Oncology's Shares Outstanding (Weighted Average) rose 303.44% to $62.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.6 million, marking a year-over-year increase of 303.44%. This contributed to the annual value of $58.4 million for FY2024, which is N/A changed from last year.
  • Pyxis Oncology's Shares Outstanding (Weighted Average) amounted to $62.6 million in Q3 2025, which was up 303.44% from $61.9 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Shares Outstanding (Weighted Average) registered a high of $62.6 million during Q3 2025, and its lowest value of $51.3 million during Q1 2024.